Major Histocompatibility Class II Pathway Is Not Required for the Development of Nonalcoholic Fatty Liver Disease in Mice
Single-nucleotide polymorphisms within major histocompatibility class II (MHC II) genes have been associated with an increased risk of drug-induced liver injury. However, it has never been addressed whether the MHC II pathway plays an important role in the development of nonalcoholic fatty liver dis...
Saved in:
Main Authors: | Gilles Willemin, Catherine Roger, Armelle Bauduret, Kaori Minehira |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2013-01-01
|
Series: | International Journal of Endocrinology |
Online Access: | http://dx.doi.org/10.1155/2013/972962 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Hypoxemic Bronchiolitis Related to Major Histocompatibility Class II Deficiency
by: S. Hammami, et al.
Published: (2013-01-01) -
Nonalcoholic Fatty Liver Disease: Its Mechanisms and Complications
by: Abdelfattah El Ouaamari, et al.
Published: (2013-01-01) -
Geometry Dynamics of α-Helices in Different Class I Major Histocompatibility Complexes
by: Reiner Ribarics, et al.
Published: (2015-01-01) -
Increasing Whole Grain Intake as Part of Prevention and Treatment of Nonalcoholic Fatty Liver Disease
by: Alastair B. Ross, et al.
Published: (2013-01-01) -
Sp17 Protein Expression and Major Histocompatibility Class I and II Epitope Presentation in Diffuse Large B Cell Lymphoma Patients
by: Kamel Ait-Tahar, et al.
Published: (2017-01-01)